ONC

BeiGene, Ltd.

Price

$358.72

return (12m)

p/e

793.52

p/bv

100.56

DIVIDEND YIELD

0.00%

ONC price

BeiGene, Ltd.

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ONC

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

3.61%

3 months

32.81%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ONC

Valuation

P/E

793.52

Sector -0.03

Industry 2.50

P/BV

100.56

Sector 1.90

Industry 2.36

P/Revenue (PSR)

84.89

Sector 1.56

Industry 1.83

EV/EBITDA

1,314.20

Sector -49.34

Industry -3.34

EV/EBIT

1,465.38

Sector -33.76

Industry -16.52

P/EBITDA

442.70

Sector -60.21

Industry -72.22

P/EBIT

509.92

Sector -58.76

Industry -65.82

P/Total Assets

56.71

Sector 0.90

Industry 1.06

P/Net Current Assets

161.88

Sector -23.35

Industry -5.85

P/Working Capital

102.09

Sector -4.31

Industry 1.60

EPS

0.45

Sector -0.74

Industry -0.59

BVPS

3.57

Sector 3.96

Industry 4.78

Efficiency

Gross Margin

88.89%

Sector 48.49%

Industry 50.04%

EBITDA Margin

23.03%

Sector -313.26%

Industry -57.18%

EBIT Margin

20.66%

Sector -182.06%

Industry -55.62%

Operating Margin

15.06%

Sector -21.96%

Industry -26.59%

Net Profit Margins

10.70%

Sector -26.08%

Industry -30.03%

Asset Turnover

0.19

Sector 0.13

Industry 0.15

Profitability

ROE

12.67%

Sector -26.91%

Industry -24.28%

ROA

7.15%

Sector -26.05%

Industry -25.14%

ROIC

40.50%

Sector -589.68%

Industry -89.29%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

3.40

Sector 1.89

Industry 2.02

Net Debt / EBITDA

-10.74

Sector -21.45

Industry -2.68

Net Debt / EBIT

-11.97

Sector -3.01

Industry -2.00

Net Debt / Equity

-0.81

Sector -0.62

Industry -0.27

Gross Debt / Equity

0.17

Sector 0.11

Industry -0.81

Equity/Assets

0.56

Sector 0.45

Industry 0.47

Liabilities/Assets

0.44

Sector 0.49

Industry 0.51

Growth

5Y Revenue CAGR

39.12%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals ONC

DRAG THE FRAME TO SEE MORE DATA

FAIR VALUE OF BeiGene, Ltd. ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$358.72

Fair Value

$6.01

Upside Return potential.

-98.32%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ONC BeiGene, Ltd.	$358.72	-	0.00%	793.52	100.56	12.67%	10.70%
LLY Eli Lilly and Compay	$1,146.64	55.66%	0.56%	38.25	-	-%	33.53%
SNY Sanofi	$44.21	-7.89%	4.00%	4.14	0.76	18.43%	14.25%
GSK GlaxoSmithKline PLC	$50.00	32.84%	3.51%	15.52	4.38	28.24%	14.54%
CRMD CorMedix Inc.	$8.41	-38.65%	0.00%	3.52	1.43	40.62%	40.49%
AMPH Amphastar Pharmaceuticals Inc.	$23.23	-20.98%	0.00%	12.90	1.32	10.23%	10.76%
RDY Dr. Reddy's Laboratories Ltd.	$12.01	-14.79%	0.69%	27.24	2.46	9.03%	10.14%
ISRG Intuitive Surgical Inc.	$365.46	-17.16%	0.00%	40.98	7.07	17.26%	28.62%
NVS Novartis AG	$160.29	27.43%	1.94%	23.95	7.28	30.39%	23.28%
TMO Thermo Fisher Scientific Inc.	$615.36	27.54%	0.29%	32.67	4.33	13.26%	15.08%
ABT Abbott Laboratories	$109.74	-15.48%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$94.56	6.67%	3.04%	22.82	2.36	10.35%	14.02%
BSX Boston Scientific Corp.	$47.77	-55.58%	0.00%	19.32	2.85	14.73%	17.49%
TMDX TransMedics Group Inc.	$87.28	-18.38%	0.00%	19.90	5.83	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$532.60	-15.99%	0.00%	36.90	26.08	70.67%	25.03%
RMD ResMed Inc.	$227.28	-14.50%	1.06%	21.68	5.07	23.41%	27.44%
HCA HCA Healthcare Inc.	$405.39	0.11%	0.74%	11.38	-27.86	-244.72%	10.07%
DHR Danaher Corporation	$207.84	5.20%	0.69%	36.61	2.79	7.61%	15.95%
COHR Coherent Inc.	$282.72	219.57%	0.00%	118.83	4.88	4.11%	6.85%
PHG Koninklijke Philips NV	$26.02	-0.39%	3.89%	19.20	1.88	9.80%	6.30%
SYK Stryker Corp.	$304.60	-20.60%	1.15%	31.24	4.86	15.55%	14.43%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ONC Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT BeiGene, Ltd.

BeiGene, Ltd.

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

2016

Time since IPO - 10 years

12.000

Employees

BeiGene, Ltd. (United States) is listed on the Nasdaq and has a market capitalization of $520.32 billion, with shareholders equity totaling $5.17 billion.

The company employs approximately 12.000 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, BeiGene, Ltd. reported $6.13 billion in revenue, generating net income of $655.71 million.

Key financial metrics include a P/E ratio of 793.52, a price-to-book (P/B) ratio of 100.56, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ONC.

Market cap

$520.32 billion

Net worth

$5.17 billion

$5,173,998,000.00

Assets

$9.18 billion

$9,175,615,000.00

Total Shares Outstanding

1.45 billion

1,450,485,000

Average Daily Trading Volume

$371.16 Thousand

$371,155.28

Sector

Health

Industry

Pharmaceutical Products

ONC

revenue by Business Segment BeiGene, Ltd.

Revenue by Region BeiGene, Ltd.

ONC revenue and profits

Financial Results ONC

DRAG THE FRAME TO SEE MORE DATA

ONC cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$97.55 36,39% (12M)

P/E

-0.87

2.73%

ROE

-178.93%

P/BV

1.56

CI - Cigna

$284.57 --4,74% (12M)

P/E

10.92

2.17%

ROE

16.04%

P/BV

1.75

CNC - Centene

$67.74 133,75% (12M)

P/E

-6.55

0.00%

ROE

-22.56%

P/BV

1.48

HUM - Humana

$405.08 33,46% (12M)

P/E

37.56

0.88%

ROE

6.72%

P/BV

2.52

SNY - Sanofi

$44.21 --1,17% (12M)

P/E

4.14

4.00%

ROE

18.43%

P/BV

0.76

LLY - Eli Lilly

$1,146.64 56,34% (12M)

P/E

38.25

0.56%

ROE

P/BV

HCA - HCA Healthcare

$405.39 --3,02% (12M)

P/E

11.38

0.74%

ROE

-244.72%

P/BV

-27.86

NVS - Novartis

$160.29 25,95% (12M)

P/E

23.95

1.94%

ROE

30.39%

P/BV

7.28